thiotepa has been researched along with Hyperplasia in 2 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ZINCA, V | 1 |
| STRIMBEANU, I | 1 |
| Zincke, H | 1 |
| Utz, DC | 1 |
| Farrow, GM | 1 |
2 other studies available for thiotepa and Hyperplasia
| Article | Year |
|---|---|
MORPHOLOGICAL ASPECTS IN EXFOLIATIVE VAGINAL CYTOLOGY FOLLOWING ANTICANCEROUS CHEMOTHERAPY.
Topics: Antineoplastic Agents; Aziridines; Breast Neoplasms; Cell Nucleus; Coloring Agents; Cyclophosphamide | 1963 |
Review of Mayo Clinic experience with carcinoma in situ.
Topics: Administration, Topical; BCG Vaccine; Carcinoma in Situ; Doxorubicin; Hematoporphyrins; Humans; Hype | 1985 |